BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ta HDK, Wang WJ, Phan NN, An Ton NT, Anuraga G, Ku SC, Wu YF, Wang CY, Lee KH. Potential Therapeutic and Prognostic Values of LSM Family Genes in Breast Cancer. Cancers (Basel) 2021;13:4902. [PMID: 34638387 DOI: 10.3390/cancers13194902] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Sun X, Zhang J, Xiao C, Ge Z. Expression profile and prognostic values of LSM family in skin cutaneous melanoma. BMC Med Genomics 2022;15:238. [DOI: 10.1186/s12920-022-01395-6] [Reference Citation Analysis]
2 Wang Z, Qi H, Zhang Y, Sun H, Dong J, Wang H. PLPP2: Potential therapeutic target of breast cancer in PLPP family. Immunobiology 2022;227:152298. [DOI: 10.1016/j.imbio.2022.152298] [Reference Citation Analysis]
3 Ku S, Liu H, Su C, Yeh I, Yen M, Anuraga G, Ta HDK, Chiao C, Xuan DTM, Prayugo FB, Wang W, Wang C. Comprehensive analysis of prognostic significance of cadherin (CDH) gene family in breast cancer. Aging 2022. [DOI: 10.18632/aging.204357] [Reference Citation Analysis]
4 Li Q, Jiang Y, Song N, Zhou B, Li Z, Lin L, Ali Sheikh MS. An Immune-Related Genetic Feature Depicted the Heterogeneous Nature of Lung Adenocarcinoma and Squamous Cell Carcinoma and Their Distinctive Predicted Drug Responses. Oxidative Medicine and Cellular Longevity 2022;2022:1-23. [DOI: 10.1155/2022/8447083] [Reference Citation Analysis]
5 Sun ZP, Tan ZG, Peng C. Long noncoding RNA LINC01419 promotes hepatocellular carcinoma malignancy by mediating miR-485-5p/LSM4 axis. Kaohsiung J Med Sci 2022. [PMID: 35748489 DOI: 10.1002/kjm2.12566] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lin H, Chen H, Zhao X, Ding T, Wang Y, Chen Z, Tian Y, Zhang P, Shen Y. Advances of exosomes in periodontitis treatment. J Transl Med 2022;20:279. [PMID: 35729576 DOI: 10.1186/s12967-022-03487-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Tzeng YT, Tsui KH, Tseng LM, Hou MF, Chu PY, Sheu JJ, Li CJ. Integrated analysis of pivotal biomarker of LSM1, immune cell infiltration and therapeutic drugs in breast cancer. J Cell Mol Med 2022. [PMID: 35692083 DOI: 10.1111/jcmm.17436] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhang H, Zhang Y, Feng Z, Lu L, Li Y, Liu Y, Chen Y. Analysis of the Expression and Role of Keratin 17 in Human Tumors. Front Genet 2022;13:801698. [DOI: 10.3389/fgene.2022.801698] [Reference Citation Analysis]
9 Ye Z, Bing A, Zhao S, Yi S, Zhan X. Comprehensive analysis of spliceosome genes and their mutants across 27 cancer types in 9070 patients: clinically relevant outcomes in the context of 3P medicine. EPMA Journal. [DOI: 10.1007/s13167-022-00279-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zhang H, Ma Y, Zhang Q, Liu R, Luo H, Wang X. A pancancer analysis of the carcinogenic role of receptor-interacting serine/threonine protein kinase-2 (RIPK2) in human tumours. BMC Med Genomics 2022;15:97. [PMID: 35473583 DOI: 10.1186/s12920-022-01239-3] [Reference Citation Analysis]
11 Susini T, Biglia N, Bounous VE. Prognostic Factors Research in Breast Cancer Patients: New Paths. Cancers (Basel) 2022;14:971. [PMID: 35205717 DOI: 10.3390/cancers14040971] [Reference Citation Analysis]
12 Chen L, Lin YH, Liu GQ, Huang JE, Wei W, Yang ZH, Hu YM, Xie JH, Yu HZ. Clinical Significance and Potential Role of LSM4 Overexpression in Hepatocellular Carcinoma: An Integrated Analysis Based on Multiple Databases. Front Genet 2021;12:804916. [PMID: 35096017 DOI: 10.3389/fgene.2021.804916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Song S, Liu J, Zhang M, Gao X, Sun W, Liu P, Wang Y, Li J. Eukaryotic translation initiation factor 3 subunit B could serve as a potential prognostic predictor for breast cancer. Bioengineered 2022;13:2762-76. [PMID: 35040374 DOI: 10.1080/21655979.2021.2017567] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ta HDK, Minh Xuan DT, Tang WC, Anuraga G, Ni YC, Pan SR, Wu YF, Fitriani F, Putri Hermanto EM, Athoillah M, Andriani V, Ajiningrum PS, Wang CY, Lee KH. Novel Insights into the Prognosis and Immunological Value of the SLC35A (Solute Carrier 35A) Family Genes in Human Breast Cancer. Biomedicines 2021;9:1804. [PMID: 34944621 DOI: 10.3390/biomedicines9121804] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Chiao CC, Liu YH, Phan NN, An Ton NT, Ta HDK, Anuraga G, Minh Xuan DT, Fitriani F, Putri Hermanto EM, Athoillah M, Andriani V, Ajiningrum PS, Wu YF, Lee KH, Chuang JY, Wang CY, Kao TJ. Prognostic and Genomic Analysis of Proteasome 20S Subunit Alpha (PSMA) Family Members in Breast Cancer. Diagnostics (Basel) 2021;11:2220. [PMID: 34943457 DOI: 10.3390/diagnostics11122220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Chou CW, Hsieh YH, Ku SC, Shen WJ, Anuraga G, Khoa Ta HD, Lee KH, Lee YC, Lin CH, Wang CY, Wang WJ. Potential Prognostic Biomarkers of OSBPL Family Genes in Patients with Pancreatic Ductal Adenocarcinoma. Biomedicines 2021;9:1601. [PMID: 34829830 DOI: 10.3390/biomedicines9111601] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]